LINE 5

Dr Feldman has broad business, medical and life-science research experience. He obtained his medical degree in London, his PhD in The Netherlands and has also worked at Harvard Medical School. Dr Feldman held clinical and academic appointments at Imperial College, London in Neonatal Infection. As a serial life-sciences entrepreneur, he founded the UK vaccine company Microscience and subsequently antimicrobial company Vmax. He then became the CEO of the hepatitis C therapeutic company RioTech based in London before establishing European operations for the New York based drug development venture firm for Paramount Biosciences, LLC. Subsequently, he went on to be Entrepreneur in Residence at Imperial Innovations in London where he co-founded the spin-out company Indigix. He then moved to New Zealand to join Pacific Channel as Executive Director and subsequently founded Line 5, the life-sciences consulting company.

Also known as: Line 5 Limited, Line 5 Ltd.

Primary location: Newmarket New Zealand